Class information for:
Level 1: CANCER NANOTECHNOLOGY//NANOSCI NANOENGN INITIAT NUSNNI//CHEMOTHERAPEUTIC ENGINEERING

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12775 819 48.0 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
520 14322 SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CANCER NANOTECHNOLOGY Author keyword 34 52% 6% 47
2 NANOSCI NANOENGN INITIAT NUSNNI Address 33 83% 2% 19
3 CHEMOTHERAPEUTIC ENGINEERING Author keyword 29 88% 2% 14
4 SHENZHEN GENE ANTIBODY THER Y Address 26 56% 4% 31
5 MOLECULAR BIOMATERIALS Author keyword 8 62% 1% 8
6 PLGA NANOPARTICLES Author keyword 7 19% 4% 34
7 PHARMACEUTICAL NANOTECHNOLOGY Author keyword 7 42% 2% 13
8 TPGS Author keyword 7 27% 3% 22
9 TPGS B PCL RAN PGA Author keyword 6 80% 0% 4
10 LIPID POLYMER HYBRID NANOPARTICLES Author keyword 5 63% 1% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CANCER NANOTECHNOLOGY 34 52% 6% 47 Search CANCER+NANOTECHNOLOGY Search CANCER+NANOTECHNOLOGY
2 CHEMOTHERAPEUTIC ENGINEERING 29 88% 2% 14 Search CHEMOTHERAPEUTIC+ENGINEERING Search CHEMOTHERAPEUTIC+ENGINEERING
3 MOLECULAR BIOMATERIALS 8 62% 1% 8 Search MOLECULAR+BIOMATERIALS Search MOLECULAR+BIOMATERIALS
4 PLGA NANOPARTICLES 7 19% 4% 34 Search PLGA+NANOPARTICLES Search PLGA+NANOPARTICLES
5 PHARMACEUTICAL NANOTECHNOLOGY 7 42% 2% 13 Search PHARMACEUTICAL+NANOTECHNOLOGY Search PHARMACEUTICAL+NANOTECHNOLOGY
6 TPGS 7 27% 3% 22 Search TPGS Search TPGS
7 TPGS B PCL RAN PGA 6 80% 0% 4 Search TPGS+B+PCL+RAN+PGA Search TPGS+B+PCL+RAN+PGA
8 LIPID POLYMER HYBRID NANOPARTICLES 5 63% 1% 5 Search LIPID+POLYMER+HYBRID+NANOPARTICLES Search LIPID+POLYMER+HYBRID+NANOPARTICLES
9 VITAMIN E TPGS 5 27% 2% 15 Search VITAMIN+E+TPGS Search VITAMIN+E+TPGS
10 PLGA TPGS 4 75% 0% 3 Search PLGA+TPGS Search PLGA+TPGS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VITAMIN E TPGS 52 46% 10% 85
2 NEW CONCEPT CHEMOTHERAPY 26 87% 2% 13
3 PLGA NANOPARTICLES 16 14% 13% 104
4 POLYETHYLENE GLYCOL SUCCINATE 12 75% 1% 9
5 COATED PLGA NANOPARTICLES 8 75% 1% 6
6 PACLITAXEL TAXOLR 7 21% 4% 30
7 POLYD L LACTIDE CO GLYCOLIDE NANOPARTICLES 7 33% 2% 17
8 LIPID POLYMER PARTICLE ASSEMBLIES 7 67% 1% 6
9 DOCETAXEL LOADED NANOPARTICLES 6 80% 0% 4
10 SUCCINATE TPGS 6 58% 1% 7

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Polymeric nanoparticles for targeted treatment in oncology: current insights 2015 5 128 19%
Vitamin E TPGS as a molecular biomaterial for drug delivery 2012 84 112 51%
PLGA-based nanoparticles: An overview of biomedical applications 2012 335 191 11%
Nanotheranostics - Application and Further Development of Nanomedicine Strategies for Advanced Theranostics 2014 30 135 17%
Vitamin E-based nanomedicines for anti-cancer drug delivery 2014 13 80 34%
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review 2013 30 87 34%
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents 2011 77 147 31%
Lipid-coated polymeric nanoparticles for cancer drug delivery 2015 1 76 32%
Lipid-enveloped hybrid nanoparticles for drug delivery 2013 24 89 28%
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer 2012 93 74 20%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NANOSCI NANOENGN INITIAT NUSNNI 33 83% 2.3% 19
2 SHENZHEN GENE ANTIBODY THER Y 26 56% 3.8% 31
3 BIOTECH BIOMED 4 36% 1.2% 10
4 NANOSCI NANOENGN INITIAT 4 67% 0.5% 4
5 NANO TRANSLAT MED 3 45% 0.6% 5
6 ENGN NANOMED 3 16% 1.8% 15
7 HENAN HEREDITARY DIS MOL TARGET DRUG TH 2 67% 0.2% 2
8 TIANJIN BIOMAT 2 18% 1.2% 10
9 ANESTHESIA NANOMED BIOMAT 1 100% 0.2% 2
10 EDWARD M COPELAND III CHAIR BREAST CANC 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000199408 NANOCAPSULES//LIPID CORE NANOCAPSULES//POLYALKYLCYANOACRYLATE
2 0.0000185696 POLYMERIC MICELLES//POLYMERIC MICELLE//PLURONIC MICELLES
3 0.0000150778 BOVINE SERUM ALBUMIN NANOPARTICLES//HUMAN SERUM ALBUMIN NANOPARTICLES//COACERVATION METHOD
4 0.0000142837 LIPID NANOCAPSULES//U1066//U646
5 0.0000127721 PLGA//MICROSPHERES//POLYLACTIDE CO GLYCOLIDE
6 0.0000116418 NAB PACLITAXEL//CREMOPHOR EL//NEW MAT BIOL
7 0.0000110927 BRAIN TARGETING//SMART DRUG DELIVERY//ANGIOPEP 2
8 0.0000106540 LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077
9 0.0000092843 SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//SOLID LIPID NANOPARTICLE
10 0.0000084268 HPMA COPOLYMERS//HPMA COPOLYMER//POLYMER THER EUT